Researchers develop a protein called NAP which protects and restores nerve cell communication in some neurodegenerative diseases.
A test that uses images of cats and dogs may prove to be a quick and effective method of predicting which patients in early stages of Parkinson's disease will develop dementia.
COVID-19 infection activates the same inflammatory response in the brain as Parkinson's disease, a new study reports.
Natural killer cells may play a critical role in regulating and restraining neuroinflammation and protein clumping associated with Parkinson's disease.
Study reveals a new mechanism that appears to reverse the build-up of protein aggregates by refolding them, rather than removing them.
Researchers have identified a mechanism that may explain how neurons falter during the earliest stages of Alzheimer's and other neurodegenerative diseases.
The Parkinson's-associated protein alpha-synuclein appears to act as a "toggle switch" that helps control vesicle transportation and gene expression. In a diseased state, this delicate balance is broken. The findings have implications for the development of new treatments for Parkinson's disease.
A protein associated with Parkinson's disease regulates neurotransmission by self association, a new study reports.
Researchers explore how people with Parkinson's disease make use of online, virtual reality environments.
Researchers improve both animal and cell models for Parkinson's disease, a new study reports.
Researchers have developed a new biomarker that will enable a rapid and inexpensive test for Parkinson's disease.
Researchers have developed a sensor that can detect early stage Parkinson's disease by analyzing a sample of a patient's breath.
